hero section gradient
11 handpicked stocks

US & China Slash Tariffs to Boost Trade

These carefully selected stocks could see growth as the US and China significantly lower trade tariffs. Our analysts have identified companies positioned to benefit from increased trade between the world's two largest economies.

Author avatar

Han Tan | Market Analyst

Published on May 3

Your Basket's Financial Footprint

Market capitalisation breakdown for the basket and investor key takeaways summarised.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and a closer alignment with broad market performance.
  • Best positioned as a core holding for diversified portfolios, not as speculative or high-growth allocation.
  • Expect steady, long-term appreciation rather than explosive short-term gains; returns are likely more moderate.
Total Market Cap
  • TSLA: $1.47T

  • AAPL: $3.90T

  • BABA: $397.68B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection focuses on companies that stand to benefit from reduced trade tensions between the US and China. With tariffs dropping dramatically (US from 145% to 30%, China from 125% to 10%), these stocks could see improved business conditions and investor confidence.

2

What You Need to Know

This 90-day tariff reduction represents a temporary easing of trade tensions that could reduce market uncertainty. While the long-term outlook depends on whether a more conclusive deal is reached by August 2025, these selected companies may benefit from this trading window.

3

Why These Stocks

We've handpicked big-name US and Chinese stocks that rely heavily on cross-border business or have significant market presence in both countries. These companies are potentially positioned to capitalize on increased trade activity and improved business sentiment.

Why You'll Want to Watch These Stocks

🌎

Global Trade Revival

As tariffs drop dramatically (US from 145% to 30%, China from 125% to 10%), these companies could see immediate benefits from reduced costs and increased business activity across borders.

🚀

Market Momentum Opportunity

Markets have already started responding positively to the tariff cuts. Getting in now could position you to benefit if the 90-day window leads to a more permanent trade agreement.

🔍

First-Mover Advantage

While many investors are still figuring out what these tariff cuts mean, you can get ahead by focusing on these carefully selected companies already positioned to benefit from US-China trade improvements.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Aerospace Stocks: Could Airbus Issues Boost Boeing?

Airbus has cut its delivery targets after discovering a significant fuselage flaw in its A320 aircraft, causing production delays and requiring widespread inspections. This situation could create a significant opening for its main competitor, Boeing, and other aerospace manufacturers to capture market share from airlines seeking to avoid delivery uncertainties.

Cargo Capacity Crisis: Which Stocks May Benefit Most?

Cargo Capacity Crisis: Which Stocks May Benefit Most?

The crash of a UPS cargo plane has led to the grounding of an entire class of aging aircraft across the logistics industry. This creates a potential investment opportunity in competing cargo carriers and aircraft manufacturers poised to fill the resulting gap in shipping capacity.

UK-US Pharma Trade Deal | Tariff-Free Market Access

UK-US Pharma Trade Deal | Tariff-Free Market Access

A new trade deal eliminates tariffs on pharmaceuticals between the UK and the US, strengthening transatlantic trade. This creates a powerful tailwind for pharmaceutical companies in both countries, potentially boosting exports, innovation, and profitability.

Frequently Asked Questions